Search Within

Lauren M Cane

Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (7)
  3. Advanced Practice Providers (5)
  4. Nursing (5)
  5. Sarcoma Service (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Gary Schwartz (7)
  2. Richard Carvajal (7)
  3. Mark Dickson (5)
  4. Heather Dials (4)
  5. Manish Shah (3)
  6. Mithat Gonen (3)

More People

Years
  1. 2011 (3)
  2. 2010 (1)
  3. 2009 (2)
  4. 2008 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancer Chemotherapy and Pharmacology (1)
  3. Clinical Cancer Research (1)
  4. Investigational New Drugs (1)
  5. JAMA - Journal of the American Medical Association (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Springer (2)
  3. American Association for Cancer Research (1)
  4. American Medical Association (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors
    Journal Article

    Dickson, M. A.; Rathkopf, D. E.; Carvajal, R. D.; Grant, S.; Roberts, J. D.; Reid, J. M.; Ames, M. M.; McGovern, R. M.; Lefkowitz, R. A.; Gonen, M.; more...
    Investigational New Drugs (2011)

    Fulltext@MSK | Save
  • A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors
    Journal Article

    Dickson, M. A.; Carvajal, R. D.; Merrill, A. H. Jr; Gonen, M.; Cane, L. M.; Schwartz, G. K.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • KIT as a therapeutic target in metastatic melanoma
    Journal Article

    Carvajal, R. D.; Antonescu, C. R.; Wolchok, J. D.; Chapman, P. B.; Roman, R. A.; Teitcher, J.; Panageas, K. S.; Busam, K. J.; Chmielowski, B.; Lutzky, J.; more...
    JAMA - Journal of the American Medical Association (2011)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pancyclin-dependentkinase (CDK) inhibitor flavopiridol
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M.; Tse, A. N.; Dials, H.; Cane, L. M.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
    Meeting Abstract

    Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I study of FOLFOX administered with flavopiridol (F) in patients with refractory solid tumors
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M. A.; Cane, L. M.; Dials, H. J.; Schwartz, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save